Picture of Stromacel logo

PROT Stromacel Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Stromacel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2007
December 31st
2008
December 31st
2009
December 31st
2010
December 31st
2011
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PRESS10-K10-K10-K10-K/A
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.17-4.97-3.86-3.47-1.38
Depreciation
Non-Cash Items4.082.811.950.291
Other Non-Cash Items
Changes in Working Capital0.660.7620.8250.7080.438
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-1.47-0.111-0.207-0.565-0.277
Capital Expenditures-0.031
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.2340-0.215-0.038
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-0.2650-0.215-0.038
Financing Cash Flow Items1.03
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.360.1110.3060.6810.316
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.37200.1-0.1-0